Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 3,966 recruiting studies in this area right now.
By phase
- Not applicable2,545
- Phase 2357
- Phase 4302
- Phase 1287
- Phase 3282
- Phase 1/Phase 2133
- Phase 2/Phase 360
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)89
- Assistance Publique - Hôpitaux de Paris69
- University of California, San Francisco39
- Johns Hopkins University30
- National Cancer Institute (NCI)28
- Hospices Civils de Lyon27
- Columbia University24
- University of Alabama at Birmingham23
- University of Oxford23
- University of Washington23
Where studies are running
- California233
- Maryland142
- Alabama93
- New York73
- Florida72
- Texas62
- Massachusetts57
- Arizona48
- Pennsylvania43
- Illinois41
Recruiting studies3,966 total
- NCT07759583Recruiting
Breathing exercises for smog-related pneumonia
This study tests two breathing techniques—Buteyko breathing and incentive spirometry—to see which better improves oxygen levels, breathing difficulty, exercise tolerance, and mucus clearance in people with pneumonia caused by air pollution.
Lahore, Punjab ProvinceAges 25–40 - NCT06579365Recruiting
Registry on H. pylori Infection Management in Argentina
This registry study tracks how H. pylori infection is managed in Argentina. It aims to collect real-world data to improve treatment for this common stomach infection.
Ciudad de Buenos AiresAges 18 years+ - NCT05888987Recruiting
New test for severe corneal infection diagnosis
This study tests a new method for identifying bacteria causing severe corneal infections. It may help doctors choose the right treatment faster by improving how the infection is identified from corneal samples.
ReimsAges 18 years+ - NCT03044509Recruiting
Testing to diagnose tuberculosis in Swiss children
This trial studies how to diagnose tuberculosis (TB) in children and teens when they are being checked after possible exposure or because TB is suspected. It may help doctors figure out faster and more accurately who has TB infection or disease.
AarauAges Up to 17 years - NCT04853186Recruiting
Cholera vaccine program monitoring and household tracking
This study monitors how cholera vaccination efforts are working in areas where cholera is common. It checks people who come to cholera treatment centers and certain household contacts to see who has cholera and follows them for surveillance.
GomaAges Any age - NCT05674656RecruitingPhase 1/Phase 2
Testing dolutegravir and rilpivirine in HIV-positive children
This study checks how safe and well two HIV medicines work in children ages 6 to under 12. It also measures drug levels in the body to guide dosing and watch for side effects.
Long Beach, CaliforniaAges 6–12 - NCT06004739Recruiting
Antibiotics for older adults with delirium and abnormal urine tests
This trial tests whether giving antibiotics helps older adults in the hospital who have delirium (sudden confusion) and signs of bacteria in their urine but no clear urinary infection. It aims to see if treatment can improve confusion and avoid unnecessary antibiotics.
Chicago, IllinoisAges 60 years+ - NCT06279741RecruitingPhase 1/Phase 2
Cell therapy to prevent lung disease in very premature babies
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
BrusselsAges Up to 1 week - NCT07757802RecruitingPhase 1
HIV vaccine nanoparticle and mRNA booster for healthy adults
This study tests a new HIV vaccine that uses tiny particles (nanoparticles) and an mRNA booster — similar to some COVID vaccines. The goal is to see if it is safe and helps your body fight HIV. It's for healthy adults who do not have HIV.
San Francisco, CaliforniaAges 18–55 - NCT07755618Enrolling by invitationPhase 1
Doxycycline levels and adherence study
This study looks at how the antibiotic doxycycline stays in your body and how well people stick to taking it. It may help find better ways to prevent infections.
Chapel Hill, North CarolinaAges 18–65 - NCT06450067Recruiting
Inaticabtagene Autoleucel for Relapsed or Refractory ALL
This trial tests a personalized cell therapy for adults with B-cell acute lymphoblastic leukemia (ALL) that has come back or hasn't responded to treatment. It may offer a new option for people who need additional treatment.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07756554Recruiting
Care at the nursing home instead of hospital
This trial tests whether treating nursing home residents at their nursing home, instead of sending them to the hospital, is a good alternative. It aims to see if this approach can improve care and avoid unnecessary hospital visits.
CopenhagenAges 18 years+ - NCT07755670Recruiting
Brain scans to understand hidradenitis suppurativa
This study uses MRI brain scans to see if brain activity differs in people with hidradenitis suppurativa (a painful skin condition) compared to healthy volunteers. It also tracks how treatment affects the brain over 3 months.
Changsha, HunanAges 18–45 - NCT07749911Recruiting
Vaccine effectiveness study for malaria in young children
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
Boromo, Boucle MouhounAges 5 months–5 years - NCT07750561Enrolling by invitation
Turkish questionnaire for facial synkinesis
This study tests a Turkish version of a questionnaire that measures abnormal facial movements (synkinesis) that can happen after facial palsy. It aims to see if the questionnaire works well for Turkish-speaking patients.
Istanbul, CevizlibağAges Up to 18 years - NCT07753681Recruiting
Chronic disease care in Zambia
This study helps improve care for people with long-term illnesses like diabetes or high blood pressure in Zambia. It aims to make sure you get regular check-ups and support.
Lusaka, Lusaka ProvinceAges Any age - NCT07751978Recruiting
HIV care support for women who inject drugs
This study tests a program to help women living with HIV who also inject drugs stay engaged in their HIV care. It aims to reduce stigma and improve health outcomes.
Kyiv, Kyiv OblastAges 18 years+ - NCT07754539RecruitingPhase 3
Testing a new pneumonia vaccine in healthy Chinese infants
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
Hezhou, GuangxiAges 1 month–3 months - NCT07758140Recruiting
At-home cervical cancer screening study
This study tests if women can collect their own samples at home to screen for cervical cancer, which could make screening easier and more comfortable. You would provide a sample and compare it to a standard doctor-collected sample.
Phoenix, ArizonaAges 25–65 - NCT06539832Recruiting
Gut bacteria and immunity in people with an abnormal blood protein
This study looks at how your gut bacteria (intestinal flora) and immune system relate to a condition called monoclonal gammopathy, where an abnormal protein is found in the blood. The trial will check samples from your blood, plasma, and stool to understand these connections.
Guanzhou, GuangdongAges 45 years+ - NCT06597578Recruiting
Registry for pacemaker and ICD lead removal
This trial is a registry that collects information from people who need to have a pacemaker or ICD lead removed. It helps doctors learn more about the procedure and how to improve care.
CologneAges 18 years+ - NCT06586983Recruiting
Hepatitis B care closer to home in Ethiopia
This trial tests a program to bring hepatitis B care to local clinics in Ethiopia, so you may not need to travel far for treatment. It is for adults who have tested positive for hepatitis B surface antigen (HBsAg), meaning they have a current hepatitis B infection.
Addis Ababa, Addis AbabaAges 18 years+ - NCT06595979Recruiting
Testing antibiotics through a brain drain for hard-to-treat infections
This trial is for adults with a serious brain infection caused by drug-resistant bacteria. It tests giving an antibiotic (polymyxin B) directly into the brain through a drain tube to see if it works better.
Hangzhou, ZhejiangAges 18–75 - NCT07749586RecruitingPhase 1/Phase 2
Study of ARV-6723 alone or with pembrolizumab for advanced solid tumors
This trial tests an experimental drug called ARV-6723, alone or with another drug called pembrolizumab, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if these combinations can help shrink tumors or slow their growth.
New York, New YorkAges 18 years+
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 3,966 recruiting infectious disease studies from the U.S. registry right now, out of 6,543 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.